Corinna Chen
Direktor/Vorstandsmitglied bei Debut Biotechnology, Inc.
Profil
Corinna Chen is currently the Director at Synvitrobio, Inc., Director at Debut Biotechnology, Inc., and Partner at Material Impact Management LLC.
Previously, Corinna held positions as Principal at Incline Therapeutics, Inc. and Vice President at Medeor Therapeutics, Inc. Corinna's education includes an MBA from Duke University and an undergraduate degree from Boston University.
Aktive Positionen von Corinna Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Debut Biotechnology, Inc.
 Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Material Impact Management LLC
 Material Impact Management LLC Investment ManagersFinance Material Impact Management LLC (Material Impact Management) is a venture capital firm founded in 2015 by Carmichael Roberts and Adam Sharkawy. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - |
Synvitrobio, Inc.
 Synvitrobio, Inc. Miscellaneous Commercial ServicesCommercial Services Synvitrobio, Inc. operates as a molecule and drug discovery firm. The company was founded by Zachary Sun, George Church, Richard Murray in 2015 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Corinna Chen
| Unternehmen | Position | Ende |
|---|---|---|
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Private Equity Investor | - |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Private Equity Investor | - |
Ausbildung von Corinna Chen
| Duke University | Masters Business Admin |
| Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Incline Therapeutics, Inc.
Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Health Technology |
Material Impact Management LLC
Material Impact Management LLC Investment ManagersFinance Material Impact Management LLC (Material Impact Management) is a venture capital firm founded in 2015 by Carmichael Roberts and Adam Sharkawy. The firm is headquartered in Boston, Massachusetts. | Finance |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
Synvitrobio, Inc.
Synvitrobio, Inc. Miscellaneous Commercial ServicesCommercial Services Synvitrobio, Inc. operates as a molecule and drug discovery firm. The company was founded by Zachary Sun, George Church, Richard Murray in 2015 and is headquartered in San Francisco, CA. | Commercial Services |
Debut Biotechnology, Inc.
Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Health Technology |